Close Menu

NEW YORK – NantHealth reported after the close of the market Thursday that its fourth quarter revenues increased nearly 3 percent to $22.9 million from $22.3 million a year earlier.

The Culver City, California-based company posted a net loss of $49.1 million, or $.45 per share, compared to a net loss of $21.6 million, or $.20 per share, in Q4 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.